51 Ductal Carcinoma In Situ With Microinvasion on Biopsy—What Are the Predictors of Upstaging?
Background Ductal carcinoma in situ with microinvasion (DCISM) follows the same management as used for DCIS. Breast-conserving surgery without sentinel lymph node biopsy is indicated, as the risk of upstaging to invasive carcinoma (> 1 mm) is low. …